Workflow
NLS Pharmaceutics .(NLSP) - 2024 Q2 - Quarterly Report

Exhibit 99.1 NLS PHARMACEUTICS LTD. UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS AS OF JUNE 30, 2024 AND DECEMBER 31, 2023 AND FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023 NLS PHARMACEUTICS LTD. UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS Page | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | Interim Condensed Balance Sheets as of June 30, 2024 (unaudited) and Decembe ...